Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Wellcome Open Research|February 19, 2021
Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health systemDiptesh Aryal, Abi Beane, Arjen M Dondorp, et al.
Trials|August 25, 2020
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsJonathan A C Sterne, Janet Diaz, Jesús Villar, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 8, 2016
Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliabilityElliott Ridgeon, Rinaldo Bellomo, John Myburgh, et al.
JAMA|September 3, 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis, Jonathan A C Sterne, Srinivas Murthy, et al.
The Lancet. Respiratory Medicine|August 8, 2021
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational studyAlexander Avidan, Charles L Sprung, Joerg C Schefold, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
Pageof 6